Related references
Note: Only part of the references are listed.Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction
C. Michael Gibson et al.
AMERICAN HEART JOURNAL (2021)
Lipoprotein(a) is robustly associated with aortic valve calcium
Yannick Kaiser et al.
HEART (2021)
High-density lipoproteins, reverse cholesterol transport and atherogenesis
Henry J. Pownall et al.
NATURE REVIEWS CARDIOLOGY (2021)
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Ioanna Gouni-Berthold et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Boren et al.
EUROPEAN HEART JOURNAL (2020)
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease
Tosha Williams et al.
MOLECULAR NEURODEGENERATION (2020)
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
Gerald F. Watts et al.
NATURE REVIEWS CARDIOLOGY (2020)
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Sotirios Tsimikas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides
Anna Wolska et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Antisense lipoprotein[a] therapy: State-of-the-art and future perspectives
Giuseppe Lippi et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk
Anurag Mehta et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Special Article - Lipoprotein(a) and calcific aortic valve stenosis: A systematic review
Raviteja R. Guddeti et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
Marja-Riitta Taskinen et al.
CURRENT ATHEROSCLEROSIS REPORTS (2019)
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
Kang H. Zheng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Vascular smooth muscle cells in atherosclerosis
Gemma L. Basatemur et al.
NATURE REVIEWS CARDIOLOGY (2019)
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yu Yamazaki et al.
NATURE REVIEWS NEUROLOGY (2019)
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
J. L. Witztum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond
Elena V. Fuior et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Apolipoprotein B Particles and Cardiovascular Disease A Narrative Review
Allan D. Sniderman et al.
JAMA CARDIOLOGY (2019)
Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease
Michael B. Boffa et al.
NATURE REVIEWS CARDIOLOGY (2019)
SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux
Wen-Jun Shen et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial A Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA CARDIOLOGY (2018)
Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases
Robert W. Mahley
CLINICAL CHEMISTRY (2017)
Mobility of HSPG-bound LPL explains how LPL is able to reach GPIHBP1 on capillaries
Christopher M. Allan et al.
JOURNAL OF LIPID RESEARCH (2017)
Monocyte-Macrophages and T Cells in Atherosclerosis
Ira Tabas et al.
IMMUNITY (2017)
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
Salome Mack et al.
JOURNAL OF LIPID RESEARCH (2017)
A Test in Context: Lipoprotein(a) Diagnosis, Prognosis, Controversies, and Emerging Therapies
Sotirios Tsimikas
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder
Charlotte Koopal et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2017)
Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism
Anna Wolska et al.
ATHEROSCLEROSIS (2017)
Evolution of human apolipoprotein E (APOE) isoforms: Gene structure, protein function and interaction with dietary factors
Patricia Huebbe et al.
AGEING RESEARCH REVIEWS (2017)
Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women
Patrick R. Lawler et al.
CLINICAL CHEMISTRY (2017)
The arterial microenvironment: the where and why of atherosclerosis
Arif Yurdagul et al.
BIOCHEMICAL JOURNAL (2016)
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)
C. Michael Gibson et al.
CIRCULATION (2016)
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Philip L. S. M. Gordts et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Familial defective apolipoprotein B-100: A review
Lars H. Andersen et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Structure, function, and genetics of lipoprotein (a)
Konrad Schmidt et al.
JOURNAL OF LIPID RESEARCH (2016)
Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification The CARDIA Study
John T. Wilkins et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
Frank M. Sacks
CURRENT OPINION IN LIPIDOLOGY (2015)
A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II
Nathan L. Meyers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
Sotirios Tsimikas et al.
LANCET (2015)
Chylomicronaemia-current diagnosis and future therapies
Amanda J. Brahm et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Apolipoprotein C-III: From Pathophysiology to Pharmacology
Giuseppe Danilo Norata et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C
Michael J. Pencina et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
The GPIHBP1-LPL Complex Is Responsible for the Margination of Triglyceride-Rich Lipoproteins in Capillaries
Chris N. Goulbourne et al.
CELL METABOLISM (2014)
Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events
Samia Mora et al.
CIRCULATION (2014)
Molecular Mechanisms of Cellular Cholesterol Efflux
Michael C. Phillips
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a) Prospective 15-Year Outcomes in the Bruneck Study
Peter Willeit et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
HDL and cardiovascular disease
Daniel J. Rader et al.
LANCET (2014)
Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
Yadong Huang et al.
NEUROBIOLOGY OF DISEASE (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Angiopoietin-like proteins: a comprehensive look
Gaetano Santulli
FRONTIERS IN ENDOCRINOLOGY (2014)
Lipoprotein(a): resurrected by genetics
F. Kronenberg et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
Gregory S. Thomas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction
Pia R. Kamstrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants
Kim G. Jackson et al.
ATHEROSCLEROSIS (2012)
Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study
Allan D. Sniderman et al.
ATHEROSCLEROSIS (2012)
Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT
Ian Tietjen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Lipase maturation factor 1: A lipase chaperone involved in lipid metabolism
Miklos Peterfy
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects The Atherosclerosis Risk in Communities (ARIC) Study
Salim S. Virani et al.
CIRCULATION (2012)
Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia
Evan A. Stein et al.
CIRCULATION (2012)
Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia
R. P. Surendran et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Apolipoprotein A-V; a potent triglyceride reducer
Stefan K. Nilsson et al.
ATHEROSCLEROSIS (2011)
Apolipoproteins: metabolic role and clinical biochemistry applications
Marek H. Dominiczak et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2011)
GPIHBP1 Is Responsible for the Entry of Lipoprotein Lipase into Capillaries
Brandon S. J. Davies et al.
CELL METABOLISM (2010)
Comprehensive Analysis of Genomic Variation in the LPA Locus and Its Relationship to Plasma Lipoprotein(a) in South Asians, Chinese, and European Caucasians
Matthew B. Lanktree et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2010)
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias
Allan Sniderman et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
The LDL Receptor
Joseph L. Goldstein et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
Anne Hiukka et al.
DIABETES (2009)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I
Eric T. Alexander et al.
JOURNAL OF LIPID RESEARCH (2009)
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Robert Clarke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Esther M. M. Ooi et al.
CLINICAL SCIENCE (2008)
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
Matthew J. McQueen et al.
LANCET (2008)
Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: A pathway for late-stage quality control
Meihui Pan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias
Jacqueline de Graaf et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Subendothelial lipoprotein retention as the initiating process in atherosclerosis -: Update and therapeutic implications
Ira Tabas et al.
CIRCULATION (2007)
Development and Physiological Regulation of Intestinal Lipid Absorption. I. Development of intestinal lipid absorption: cellular events in chylomicron assembly and secretion
Dennis D. Black
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappa B activation
Akio Kawakami et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells
Akio Kawakami et al.
CIRCULATION (2006)
Scavenger receptors in atherosclerosis: Beyond lipid uptake
Kathryn J. Moore et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease
AD Sniderman et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]
WJ Cain et al.
JOURNAL OF LIPID RESEARCH (2005)
Apolipoprotein A-V-heparin interactions - Implications for plasma lipoprotein metabolism
A Lookene et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Quantitative evaluation of the contribution of weak lysine-binding sites present within apolipoprotein(a) kringle IV types 6-8 to lipoprotein(a) assembly
L Becker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
N Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A review of CETP and its relation to atherosclerosis
GJ de Grooth et al.
JOURNAL OF LIPID RESEARCH (2004)
Apolipoprotein B100 exit from the endoplasmic reticulum (ER) is COPII-dependent, and its lipidation to very low density lipoprotein occurs post-ER
V Gusarova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Identification of a lipoprotein lipase cofactor-binding site by chemical cross-linking and transfer of apolipoprotein C-II-responsive lipolysis from lipoprotein lipase to hepatic lipase
TL McIlhargey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lipoprotein lipase: structure, function, regulation, and role in disease
JR Mead et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
K Olin-Lewis et al.
JOURNAL OF LIPID RESEARCH (2002)
Complexity in the secretory pathway: The assembly and secretion of apolipoprotein B-containing lipoproteins
EA Fisher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: Lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase
HQ Liu et al.
BIOCHEMISTRY (2000)
ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins
JF Oram et al.
CURRENT OPINION IN LIPIDOLOGY (2000)
Hydrolysis of phospholipids by purified milk lipoprotein lipase - Effect of apoprotein CII, CIII, A and E, and synthetic fragments
DA Lambert et al.
CLINICA CHIMICA ACTA (2000)
Share Paper
